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substantial amount of haemodynamic data which is available about the 
human cerebral circulation, in particular regarding the myogenic 
response. Nevertheless, this monograph provides much information 
about the properties of the cerebral vasculature, and may be useful as 
a source of reference for research workers concerning this important 
area. 
M.J. Mulvany 
Methods to Assess DNA Damage and Repair Interspecies Comparisons; Edited by R.G. Tardiff, P.H.M. Lohman and G.N. Wogan, 
Wiley and Sons; Chichester, 1994; xxiv + 257 pages. $45.00. ISBN O-471-94256-1. 
This volume represents even contributed papers and a joint report provides a good overview which is still timely. Also, the chapter on 
prepared at a workshop held at the National Institute of Environmental shuttlevectors by Wood, Verghis and Essigman is useful and gives the 
Health Sciences (NIEHS), Research Triangle Park, North Carolina, reader ample background for the understanding of these types of 
USA in March 1990. experiments which have been important in the field. 
In this fast moving field of DNA damage and repair, the 4.5 year 
publication time unfortunately renders many of the papers somewhat 
out of date. There has been major new technical and conceptual 
developments since 1990, and in the area of DNA repair our 
understanding has changed dramatically. Apart from this severe 
deficiency there are some well written, comprehensive chapters in this 
book that gives the reader a useful perspective. 
The book starts with 3 chapters of general conclusion and 
recommendation. The recommendations here are appropriate and 
should generate interest, and provides a source of direction in the field. 
Whereas the chapter on DNA repair considerations is a bit outdated, 
the one on DNA damage provides some useful considerations and 
recommendations in the area of studying structure-activity 
relationships, and may be useful to have in major libraries. 
In the area of DNA damage, chapters 5, 12 and 13 are useful. The 
chapter by Beland and Poirier on different types of DNA damage V.A. Bohr 
The Tachykinin Receptors; Edited by S.H. Buck, Humana Press; Totowa, New Jersey, 1994; xi + 630 pages. $125.00. 
ISBN O-89603- 266-3. 
This volume is a timely and valuable addition to the series ‘The 
Receptors’ edited by David B. Bylund. The work satisfies a real need 
for information and clarification for both the peptide pharmacologist 
and the more general reader in what has become a complex area of 
research. The contributors have tried hard to make a specialized and 
rapidly advancing field more generally accessible. In this regard, it is 
gratifying that, after several years of often acrimonious dispute, there 
is agreement among the authors regarding nomenclature for both the 
tachykinin ligands and their receptors. Neurokinin A and neurokinin 
B replace earlier terms such as substance K and neuromedin K and the 
NK,, NK, and NK, classification of receptor subtypes is used 
exclusively throughout. The poor confused reader is entitled to a sigh 
of relief. In general, the chapters are well referenced and provide a 
concise review of the state of our knowledge, at least until the end of 
1993. 
Two introductory chapters provide the reader with an historical 
perspective as to how the study tissues as diverse as the salivary gland 
of the octopus, the skin of South American frogs and the rat vas 
deferens has led to our understanding of the multiplicity of the 
tachykinin peptides and the selectivity of their receptors. 
Methodological chapters describe, in sufficient detail to be of use to 
someone who actually proposes to perform the experiments, the 
techniques of radioligand binding assays, the use of recently available 
selective agonists and antagonists to characterize receptor subtypes and 
autoradiographic techniques to localize tachykinin receptors in both 
the brain and peripheral tissues. Up-to-date chapters on the molecular 
biology of tachykinin receptors summarize clearly the results of 
molecular cloning experiments in different mammalian species and the 
attempts to identify ligand binding sites in a way that is detailed but 
accessible to the general reader. More specialized chapters discuss post- 
receptor binding events and effects of tachykinins on ion-channels. 
The pharmacologist is very well served by chapters describing the 
properties of the wide range of synthetic peptide, ‘peptidoid’ and non- 
peptide tachykinin receptor antagonists and by the comprehensive 
discussion as to whether their use in mammalian test systems 
necessitates the use of a more complex classification of receptor 
subtypes. The reader whose interest is primarily clinical may be a little 
disappointed by the more cursory treatment of the importance of 
tachykinin receptors in pathophysiology in the later chapters of the 
book. Nevertheless, attempts have been made to assess the role of the 
NK, receptor in nociception and the analgesic possibilities of suitable 
antagonists together with the importance of tachykinins and their 
receptors in the visual system, in cardiovascular regulation and in the 
functions of the urogenital, respiratory and gastrointestinal tracts. A 
final chapter provides detailed evidence for the involvement of 
tachykinin receptors in inflammatory bowel disease and in the 
responses to injuries and insults to tissues of the CNS. 
Although I suspect hat the book is targetted primarily towards those 
workers actively involved in peptide receptor pharmacology, I can 
strongly recommend this book to a wider readership, for example, as 
a teaching aid in graduate and advanced undergraduate courses. 
J. Michael Conlon 
Royal Microscopical Society Microscopy Handbooks. No. 29: Flow Cytometry; by M.G. Ormerod, BIOS Scientific Publishers Limited; 
Oxford, 1994; xi + 77 pages. $25.00. ISBN 1 872748 39 2. 
This small volume is clearly meant o serve as a fast introduction to the 
more and more diversified field of flow cytometry. This is a daunting 
task to accomplish in a mere 77 pages, and while it reads very well, it 
is not an unqualified success. 
First, the important section on how a flow cytometer works 
(‘Instrumentation’) is far too short to give the novice a realistic view 
on the logistics of the machine. Moreover, figures seem to have been 
produced during the early Macintosh era, and several of them are not 
very informative (especially the one on the lay-out of ‘a typical flow 
cytometer’). Finally, while the text on optics might be very informative 
for the reader with some prior experience at the flow cytometer, itmust 
be confusing for the novice. 
That being said, the remainder of the book falls well within its aims 
with highly informative and didactive sections on fluorescence, 
immunofluorescence, analysis of DNA, cell proliferation and death and 
a short section on other applications. In the appendix section a good 
addition is that on ‘Learned Societies’. 
A great strength of the book is that references have been chosen with 
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the utmost care. This means that issues, which are necessarily dealt with 
in a synoptical manner (and fluorescence compensation is certainly one 
of them) can be easily looked up for the curious beginner. 
All in all then, a good volume to give to your students and 
315 
technicians, but probably not your post-dots. At its price, it should 
nevertheless be a welcome addition to any flow cytometry library, and 
with some improvement i  should definitely become a must. 
Peter Hokland 
From Genotype to Phenotype; Edited by SE. Humphries and S. Malcolm, BIOS Scientific Publishers Ltd.; Oxford, 1994; 290 pages. 
$99.00. ISBN l-872748-62-7. 
The editors state in the preface: “14 authors, each expert in their field, 
explore the problems of how the effect of different mutations - the 
‘genotype’ of the individual - are modulated to produce variability in 
the clinical symptoms - the ‘phenotype’ shown by the patient”. This 
statement and the title of the book are exciting, because the genotype/ 
phenotype relationship right now is the focus of many discussions about 
genetic diseases. The book covers a wide variety of diseases, which in 
the order of chapters are: Cystic fibrosis, Collagen diseases, Gauchers 
disease, Familial hypercholesterolernia, Charcot-Marie-Tooth disease, 
Wilms’ tumour, Myotonic dystrophy, Fragile X, Somatic mosaicism, 
Chimerism and X-inactivation, Mitochondrial DNA diseases, 
Diabetes, Coronary artery diseases, and gene therapy of dyslipidemias. 
This very diverse organisation of the book is both a strength and a 
weakness. The strength is that each disease and diseased gene is covered 
by researchers actually working in the field, assuring that data and 
conceptions are up to date, and that questions treated are relevant o 
other researchers in the field. For the clinical geneticist, reading this 
book is a nice way of being updated on a variety of diseases, in which 
molecular genetic research has opened new areas for diagnosis and 
predictions of clinical outcome. As a molecular geneticist it has also 
been a pleasure for me to get up-to-date information about diseases, 
of which I had only heard from colleagues and at conferences on 
genetics. However, this very broad selection of themes is also a 
weakness of the book. One can ask why this particular selection of 
articles has been collected. There is no natural relationship between the 
chapters. However, in all cases the molecular elucidation of the disease 
mechanisms resulted in a stage of knowledge, from which it is possible 
to answer some of the questions concerning genotype/phenotype 
relationships. 
informatively, and especially the chapter by Mark Hirst on Fragile X 
is exciting, with very good discussions about the dynamics and 
expansion of the CGG triplet within the FMRl (fragile X mental 
retardation) gene, the structure and expression of the gene, and the 
mechanism of the expansion. 
To comment on all themes is impossible. I will restrict myself to a 
few of the chapters representing the various types of diseases. 
The chapter written by Anne Soutar on Familial 
Hypercholesterolemia certainly broadens out the often narrow 
discussions in journal papers. Since I have some knowledge of the 
current state of discussions among researchers in Familial 
Hypercholesterolemia, I highly value the chapter. It has only recently 
been possible for researchers working on this disease to embark on the 
correlation between the site and type of mutations in the LDL-receptor 
gene and the clinical expression of the disease. Anne Soutar sums up 
very nicely the current knowledge, i.e. that for homozygous patients 
with LDL-receptor defects there seems to exist a correlation between 
the severity of the mutation and the severity of the disease, but that the 
clinical expression in heterozygous patients are much more - and to a 
large extent - governed by other factors, both genetical and 
environmental. This chapter is a delight to read. Steve Humphries, one 
of the editors, also provides a chapter on coronary artery disease, 
especially focused on the discussion about the variability gene concept, 
which is based on the hypothesis that some genes affect the level of a 
risk factor and others determine the variability. It is an interesting 
concept which can be applied to many other diseases, that are 
influenced by risk factors, such as susceptibility genes. Susceptibility 
genes are the main theme in the chapter on Diabetes. A good update 
is given for instance on the susceptibility role of certain HLA 
haplotypes. I cannot fully judge the originality of the information and 
discussion given by Hitman, Fennessy and Metcalfe, but the discussion 
is certainly interesting from a more general point of view as a model- 
study in polygenic and multifactorial diseases. 
One of the more exciting developments during the last few years has In conclusion, this book is a good initiative to substantiate the very 
been the elucidation of the dynamic mutations in Myotonic dystrophy difficult discussions about the genotype/phenotype r lationship, which 
and the Fragile-X syndrome, in which the disease-causing mutations in certain - perhaps in most -diseases is not only influenced by the type 
are expansions of trinucleotide repeats, the array length of which seems of mutation in the respective gene, but even more by susceptibility 
to account for the anticipation, i.e. the phenomenon that the disease factors, modifying genes, and environmental conditions. The theme will 
most often deteriorates from one generation to the next once it has explode and we are just waiting for the next book. 
occurred in a family. The authors have written these two chapters very Niels Gregersen 
